← All Illinois bills

SB3337Introduced in the Senate

DPH-LUNG CANCER STUDY

IntroducedSenate Assignments

Introduced by Adriane Johnson, District 30

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Authorizes the Department of Public Health to conduct a study on lung cancer biomarkers, including, but not limited to, the anaplastic lymphoma kinase gene. Provides that the study may focus on identifying genetic variations in lung cancer that are linked to increased risks, genetic variations that are linked to treatment resistance, and genetic variations that are linked to specific disease subtypes. Provides that the Department of Public Health may enter into contracts, grants, or other agreements for the purpose of completing the study. Provides for the repeal of these provisions on January 1, 2029.

Where it stands

Rule 3-9(a) / Re-referred to Assignments

May 22, 2026

How did lawmakers vote?

No recorded vote is available for this bill yet.

What do people think?

Citizen Voice

How would you vote on this bill?

An unofficial public opinion poll. It does not affect the bill or the official vote.

One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.

Bill history

  1. Filed with Secretary by Sen. Adriane L. Johnson

  2. First Reading

  3. Referred to Assignments

  4. Assigned to Appropriations- Health and Human Services

  5. Rule 2-10 Committee Deadline Established As April 24, 2026

  6. Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2026

  7. Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026

  8. Rule 3-9(a) / Re-referred to Assignments

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.